Published July 26, 2023 | Version v1
Journal article

MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer

Contributors

Others:

Description

No abstract available

Abstract

International audience

Additional details

Identifiers

URL
https://inserm.hal.science/inserm-04527070
URN
urn:oai:HAL:inserm-04527070v1

Origin repository

Origin repository
UNICA